Contemporary conflicts have become more complex, increasingly fragmented and intractable, with many interrelated elements that raise serious implications to the international, regional and local communities to move beyond challenges. Transnational forces of violent extremism and organized crime profit from these fragile environments to build on their capacities and finance their sources. One such way is the increased flow of counterfeit medication as a lucrative source of income. Still too often overlooked and unclear, the links between counterfeit medicine and organized crime groups need policy makers, law enforcers, pharmaceutics and rights holders to become fully aware of the short and long-term consequences of this interrelation in order to develop preventive methods to counter the proliferation of this phenomenon. According to the world health organization (who), counterfeit medicine accounts for nearly 10% of readily available medicament, which represented a loss of approximately $75 billion to $600 billion between 2010 and 2015 from the pharmaceutical industry..